会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 91. 发明授权
    • 3,7-Diazabicyclo [3.3.1] nonanes having anti-arrhythmic activity
    • 具有抗心律不齐活性的3,7-二氮杂双环[3.3.1]壬烷
    • US4451473A
    • 1984-05-29
    • US398801
    • 1982-07-16
    • Karoly NadorGabor KraissKatalin SinkoMargit ParoczaiEgon KarpatiLaszlo Szporny
    • Karoly NadorGabor KraissKatalin SinkoMargit ParoczaiEgon KarpatiLaszlo Szporny
    • A61K31/395A61K31/435A61K31/48A61K31/4995A61P9/06C07D451/14C07D471/08A61K31/44
    • C07D471/08Y10S514/821
    • New bicyclic compounds of the general formula (I), ##STR1## wherein R.sup.1 and R.sup.2 each represent a C.sub.1-6 alkyl group, andR.sup.3 is an etherified hydroxy group of the formula --CR.sup.4, wherein R.sup.4 is benzyl group, benzhydryl group or a phenyl group bearing optionally a phenyl or a trihalomethyl substituent or one or more halogen substituent(s), orR.sup.3 is an esterified hydroxy group of the formula --OCO--R.sup.5, which representsa phenyl-(C.sub.1-5 alkyl)-carbonyloxy group,a cinnamoyloxy group having optionally a halogen or one or more C.sub.1-4 alkoxy substituent(s),a benzoyloxy group having optionally a C.sub.1-4 alkyl, phenyl or trihalomethyl substituent or one or more C.sub.1-4 alkoxy substituent(s), one or more halo substituent(s) and/or nitro substituent,a benzyloyloxy group,a xanthene-9-carbonyloxy group,an optionally substituted naphthoyloxy group, oran acyloxy group derived from a five- or six-membered heterocyclic carboxylic acid bearing optionally a halo substituent on the ring,are prepared by etherifying or esterifying a bicyclic compound of the general formula (II), ##STR2## wherein R.sup.1 and R.sup.2 are as defined above. The new compounds according to the invention possess anti-arrhythmic effects and can be applied to advantage in the therapy of cardiac rhythm disorders.
    • 通式(I)的新的双环化合物,其中R 1和R 2各自表示C 1-6烷基,R 3是式-CR 4的醚化羟基,其中R 4是苄基,二苯甲基 基团或任选带有苯基或三卤甲基取代基或一个或多个卤素取代基的苯基,或R3是式-OCO-R5的酯化羟基,其代表苯基 - (C 1-5烷基) - 具有任选卤素或一个或多个C 1-4烷氧基取代基的肉桂酰氧基,任选具有C 1-4烷基的苯甲酰氧基,苯基或三卤甲基取代基或一个或多个C 1-4烷氧基取代基, ,一个或多个卤素取代基和/或硝基取代基,苯甲酰氧基,呫吨-9-羰氧基,任选取代的萘氧基或衍生自五元或六元杂环羧酸的酰氧基 任选地,环上的卤素取代基通过醚化制备 或酯化通式(II)的双环化合物,其中R 1和R 2如上所定义。 根据本发明的新化合物具有抗心律失常作用,可用于治疗心律失常的优点。
    • 98. 发明授权
    • Nitrogen-containing polycyclic compounds and a process for the
preparation thereof
    • 含氮多环化合物及其制备方法
    • US4054571A
    • 1977-10-18
    • US614151
    • 1975-09-17
    • Csaba SzantayLajor SzaboGyorgy KalausEgon KarpatiLaszlo Szporny
    • Csaba SzantayLajor SzaboGyorgy KalausEgon KarpatiLaszlo Szporny
    • C07D471/06A61K31/4375A61K31/4745C07D461/00C07D471/04
    • C07D461/00
    • The invention relates to new eburnamenine derivatives of the general formula (I), ##STR1## wherein R.sub.1 stands for an alkyl group,R.sub.2 stands for a carboxy group, a functional carboxy derivative (preferably an ester group) or a group convertable into carboxy group or a functional derivative thereof (preferably cyano group), andX.sup.- is an anion derived from an acid,And the corresponding free bases.These compounds are valuable intermediates of the preparation of eburnamenine derivatives with advantageous therapeutical effects.The above compounds are prepared as follows: a compound of the general formula (II), ##STR2## wherein R.sub.1 has the same meanings as defined above, is reacted with a compound of the general formula (III), ##STR3## wherein R.sub.2 has the same meanings as defined above and Y is halogen, and, if desired, a thus-obtained compound of the general formula (I), wherein R.sub.1 and R.sub.2 each have the same meanings as defined above and X.sup.- is a halide ion, is reacted with an acid, and/or, if desired, a compound of the general formula (I), wherein R.sub.1 and X.sup.- each have the same meanings as defined above and R.sub.2 is cyano or an ester group, is subjected to hydrolysis, and/or, if desired, a compound of the general formula (I), wherein R.sub.1, R.sub.2 and X.sup.- each have the same meanings as defined above, is treated with a base.
    • 本发明涉及通式(I),其中R1代表烷基,R2代表羧基,官能羧基衍生物(优选酯基)或可转化基团的新颖的本本母胺衍生物 羧基或其功能性衍生物(优选氰基),X是衍生自酸的阴离子,和相应的无碱基。